Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Assembly Biosciences
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Body mass index of 18 - 36 kg/m\^2 and body weight ≥45 kg
HBeAg ≥500 IU/mL at Screening
In good general health except for chronic HBV infection for ≥6 months documented, for example, by at least two measurements of HBsAg positivity and/or detectable HBV DNA ≥6 months apart
Lack of cirrhosis or advanced liver disease
You may not be if
Prior treatment for chronic HBV infection with lamivudine, telbivudine, adefovir, standard of care nucleoside or nucleotide analogue (NrtI), HBV core inhibitors, or an investigational agent for HBV infection
History or evidence of advanced liver disease or hepatic decompensation (including jaundice, ascites, portal hypertension, gastrointestinal bleeding, esophageal varices, hepatic encephalopathy)
History or presence of clinically significant medical conditions requiring frequent medical management or pharmacologic or surgical treatment
Clareo Health | A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection
